经尿道等离子剜除术治疗前列腺增生症的疗效分析  

Efficacy of transurethral plasmakinetic enucleation of prostate in treatment of prostatic hyperplasia

作　　者：刘小勇[1] 向宸辉[1] 陈胜龙[1] 王鹏桥[1] 卢芳 康蓉 

机构地区：[1]成都医学院第一附属医院泌尿外科,四川成都610500

出　　处：《西部医学》2018年第2期212-215,共4页Medical Journal of West China

摘　　要：目的探讨经尿道等离子剜除术治疗前列腺增生症的疗效。方法将236例前列腺增生症患者随机分为对照组和观察组,每组各118例。对照组患者采用经尿道前列腺等离子双极电切术(TPKRP);观察组患者采用经尿道等离子剜除术(TPKEP)治疗。比较两组患者的手术时间、切除前列腺重量、术中出血量、术后膀胱冲洗时间、术后导尿管留置时间以及两组患者术后6月膀胱残余尿量、最大尿流率、不良反应发生率、IPSS及生活质量评分(QOL)。结果观察组手术时间、术后留置导尿和膀胱冲洗时间分别短于对照组(P<0.05);前列腺切除体重量大于对照组(P<0.05);观察组术中出血量少于对照组(P<0.05);观察组不良反应发生率低于对照组(P<0.05);术后6月观察组IPSS和QOL评分、膀胱残余尿量均低于对照组(P<0.05),而最大尿流率(Qmax)和总临床有效率分别高于对照组(P<0.05)。结论经尿道前列腺剜除术治疗前列腺增生较经尿道前列腺等离子双极电切术临床疗效更高,具有手术创伤小、术中出血少、手术时间短、术后复发率低等优点,可在临床推广应用。Objective To analysis the therapeutic effects of transurethral plasmakinetic enucleation of prostate （TPKEP） for benign prostatic hyperplasia （BPH）. Methods 236 patients with prostatic hyperplasia were randomly assigned to observation group and control group. One hundred and eighteen patients in control group were treated with transurethral plasmakinetic resection of the prostate （TPKRP）, while one hundred eighteen patients in experimental group were treated with TPKEP. The data including operation time, the weight of the enucleated tissue, bleeding volume, bladder irrigation time, retention time of catheterization, complication incidence, residual urine volume （RUV）, maximum urinary flow rate （Qmax）, the scores of IPSS and QOL were recorded and compared in the two groups. Results The operation time, intraoperative blood loss, complication incidence, retention time of catheterization and bladder irrigation in the observation group were significantly lower than those in the control group （P〈0.05）. The weight of prostate tissue in the observation group was heavier than that in the control group（P〈0.05）. After treatment, the RUV and the scores of IPSS, QOL of observation group were lower than those in the control group （ P〈0.05）, while Qmax and total clinical efficacy of observation group were higher than those in the control group （P〈0.05）. Conclusion Compared with TPKRP treatment, TPKEP treatment for patients with BPH can significantly improve clinic efficacy and reduce the rate of surgical complications.

关 键 词：TPKEP TPKRP 前列腺增生 疗效分析 

分 类 号：R697.3[医药卫生—泌尿科学]